English
简体中文
Total: £ 56.28
Published Date: 2025-06-25 | Pages: 128 | Tables: 130 | Medical Care
In 2024, the global market size of Natural Killer Cell Therapy was estimated to be worth US$ 393 million and is forecast to reach approximately US$ 1758 million by 2031 with a CAGR of 24.2% during the forecast period 2025-2031.
Cell therapy, a new therapeutic approach that uses a patient"s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body"s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Cancer
Gastrointestinal Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Natural Killer Cell Therapy in global and regional level.
Chapter 3: Detailed analysis of Natural Killer Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natural Killer Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Natural Killer Cell Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Natural Killer Cell Therapy Market Size Estimates and Forecasts
2.2 Natural Killer Cell Therapy Market Size by Region: 2024 Versus 2031
2.2.1 Global Natural Killer Cell Therapy Revenue by Region: 2020-2025
2.2.2 Global Natural Killer Cell Therapy Revenue Forecast by Region (2026-2031)
2.2.3 Global Natural Killer Cell Therapy Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Natural Killer Cell Therapy Revenue by Type (2020-2031)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Natural Killer Cell Therapy Revenue by Application (2020-2031)
3.2.2 Global Natural Killer Cell Therapy Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 NK Cell Therapies of Natural Killer Cell Therapy Revenue Market Share by Application
3.3.2 NK Cell Directed Antibodies of Natural Killer Cell Therapy Revenue Market Share by Application
4 Global Natural Killer Cell Therapy by Company
4.1 Global Natural Killer Cell Therapy Revenue by Company (2020-2025)
4.2 Global Natural Killer Cell Therapy Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Natural Killer Cell Therapy Companies around the World: Ranking by Revenue
4.3.2 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Natural Killer Cell Therapy Companies Headquarters & Product Type
4.4.1 Global Natural Killer Cell Therapy Companies Headquarters
4.4.2 Date of International Companies Enter into Natural Killer Cell Therapy Market
4.4.3 Global Natural Killer Cell Therapy Companies Product & Service
4.4.4 NK Cell Therapies Revenue Market Share of Natural Killer Cell Therapy by Company
4.4.5 NK Cell Directed Antibodies Revenue Market Share of Natural Killer Cell Therapy by Company
4.5 Global Natural Killer Cell Therapy Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Nektar Therapeutics
5.1.1 Nektar Therapeutics Corporation Information
5.1.2 Nektar Therapeutics Description, Business Overview
5.1.3 Nektar Therapeutics Natural Killer Cell Therapy Products Offered
5.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.1.5 Nektar Therapeutics Natural Killer Cell Therapy Revenue by Product in 2024
5.1.6 Nektar Therapeutics Natural Killer Cell Therapy Revenue by Application in 2024
5.1.7 Nektar Therapeutics Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.1.8 Nektar Therapeutics Recent Developments
5.2 Innate Pharma SA
5.2.1 Innate Pharma SA Corporation Information
5.2.2 Innate Pharma SA Description, Business Overview
5.2.3 Innate Pharma SA Natural Killer Cell Therapy Products Offered
5.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.2.5 Innate Pharma SA Natural Killer Cell Therapy Revenue by Product in 2024
5.2.6 Innate Pharma SA Natural Killer Cell Therapy Revenue by Application in 2024
5.2.7 Innate Pharma SA Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.2.8 Innate Pharma SA Recent Developments
5.3 Affimed
5.3.1 Affimed Corporation Information
5.3.2 Affimed Description, Business Overview
5.3.3 Affimed Natural Killer Cell Therapy Products Offered
5.3.4 Affimed Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.3.5 Affimed Natural Killer Cell Therapy Revenue by Product in 2024
5.3.6 Affimed Natural Killer Cell Therapy Revenue by Application in 2024
5.3.7 Affimed Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.3.8 Affimed Recent Developments
5.4 Chipscreen Biosciences
5.4.1 Chipscreen Biosciences Corporation Information
5.4.2 Chipscreen Biosciences Description, Business Overview
5.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Products Offered
5.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.4.5 Chipscreen Biosciences Natural Killer Cell Therapy Revenue by Product in 2024
5.4.6 Chipscreen Biosciences Natural Killer Cell Therapy Revenue by Application in 2024
5.4.7 Chipscreen Biosciences Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.4.8 Chipscreen Biosciences Recent Developments
5.5 Glycostem Therapeutics
5.5.1 Glycostem Therapeutics Corporation Information
5.5.2 Glycostem Therapeutics Description, Business Overview
5.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Products Offered
5.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.5.5 Glycostem Therapeutics Natural Killer Cell Therapy Revenue by Product in 2024
5.5.6 Glycostem Therapeutics Natural Killer Cell Therapy Revenue by Application in 2024
5.5.7 Glycostem Therapeutics Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.5.8 Glycostem Therapeutics Recent Developments
5.6 Fate Therapeutics
5.6.1 Fate Therapeutics Corporation Information
5.6.2 Fate Therapeutics Description, Business Overview
5.6.3 Fate Therapeutics Natural Killer Cell Therapy Products Offered
5.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.6.5 Fate Therapeutics Natural Killer Cell Therapy Revenue by Product in 2024
5.6.6 Fate Therapeutics Natural Killer Cell Therapy Revenue by Application in 2024
5.6.7 Fate Therapeutics Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.6.8 Fate Therapeutics Recent Developments
5.7 Dragonfly Therapeutics
5.7.1 Dragonfly Therapeutics Corporation Information
5.7.2 Dragonfly Therapeutics Description, Business Overview
5.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Products Offered
5.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.7.5 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue by Product in 2024
5.7.6 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue by Application in 2024
5.7.7 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.7.8 Dragonfly Therapeutics Recent Developments
5.8 Kiadis Pharma
5.8.1 Kiadis Pharma Corporation Information
5.8.2 Kiadis Pharma Description, Business Overview
5.8.3 Kiadis Pharma Natural Killer Cell Therapy Products Offered
5.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.8.5 Kiadis Pharma Natural Killer Cell Therapy Revenue by Product in 2024
5.8.6 Kiadis Pharma Natural Killer Cell Therapy Revenue by Application in 2024
5.8.7 Kiadis Pharma Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.8.8 Kiadis Pharma Recent Developments
5.9 Nkarta Therapeutics
5.9.1 Nkarta Therapeutics Corporation Information
5.9.2 Nkarta Therapeutics Description, Business Overview
5.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Products Offered
5.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.9.5 Nkarta Therapeutics Natural Killer Cell Therapy Revenue by Product in 2024
5.9.6 Nkarta Therapeutics Natural Killer Cell Therapy Revenue by Application in 2024
5.9.7 Nkarta Therapeutics Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.9.8 Nkarta Therapeutics Recent Developments
5.10 NantKwest
5.10.1 NantKwest Corporation Information
5.10.2 NantKwest Description, Business Overview
5.10.3 NantKwest Natural Killer Cell Therapy Products Offered
5.10.4 NantKwest Natural Killer Cell Therapy Revenue and Gross Margin (2020-2025)
5.10.5 NantKwest Natural Killer Cell Therapy Revenue by Product in 2024
5.10.6 NantKwest Natural Killer Cell Therapy Revenue by Application in 2024
5.10.7 NantKwest Natural Killer Cell Therapy Revenue by Geographic Area in 2024
5.10.8 NantKwest Recent Developments
6 North America
6.1 North America Natural Killer Cell Therapy Market Size YoY Growth 2020-2031
6.2 North America Natural Killer Cell Therapy Market Facts & Figures by Country (2020-2031)
6.3 North America Natural Killer Cell Therapy Revenue by Type (2020-2025)
6.4 North America Natural Killer Cell Therapy Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Natural Killer Cell Therapy Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Natural Killer Cell Therapy Revenue by Type (2020-2025)
7.4 Asia-Pacific Natural Killer Cell Therapy Revenue by Application (2020-2025)
8 Europe
8.1 Europe Natural Killer Cell Therapy Market Size YoY Growth 2020-2031
8.2 Europe Natural Killer Cell Therapy Market Facts & Figures by Country (2020-2031)
8.3 Europe Natural Killer Cell Therapy Revenue by Type (2020-2025)
8.4 Europe Natural Killer Cell Therapy Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Natural Killer Cell Therapy Market Size YoY Growth 2020-2031
9.2 Latin America Natural Killer Cell Therapy Market Facts & Figures by Country (2020-2031)
9.3 Latin America Natural Killer Cell Therapy Revenue by Type (2020-2025)
9.4 Latin America Natural Killer Cell Therapy Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Natural Killer Cell Therapy Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Natural Killer Cell Therapy Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Natural Killer Cell Therapy Revenue by Type (2020-2025)
10.4 Middle East and Africa Natural Killer Cell Therapy Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Natural Killer Cell Therapy Supply Chain Analysis
11.2 Natural Killer Cell Therapy Key Raw Materials and Upstream Suppliers
11.3 Natural Killer Cell Therapy Clients Analysis
11.4 Natural Killer Cell Therapy Sales Channel and Sales Model Analysis
11.4.1 Natural Killer Cell Therapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Natural Killer Cell Therapy Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Natural Killer Cell Therapy Distributors
12 Natural Killer Cell Therapy Market Dynamics
12.1 Natural Killer Cell Therapy Industry Trends
12.2 Natural Killer Cell Therapy Market Drivers
12.3 Natural Killer Cell Therapy Market Challenges
12.4 Natural Killer Cell Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Natural Killer Cell Therapy Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Natural Killer Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Natural Killer Cell Therapy Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Natural Killer Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Natural Killer Cell Therapy Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Natural Killer Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Natural Killer Cell Therapy Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 11. Natural Killer Cell Therapy Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Natural Killer Cell Therapy Players by Revenue (US$ Million) in 2024
Table 13. Global Natural Killer Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
Table 15. Global Natural Killer Cell Therapy Companies Headquarters
Table 16. Date of International Companies Enter into Natural Killer Cell Therapy Market
Table 17. Global Natural Killer Cell Therapy Companies Product & Service
Table 18. Global Natural Killer Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 19. Nektar Therapeutics Corporation Information
Table 20. Nektar Therapeutics Description and Business Overview
Table 21. Nektar Therapeutics Natural Killer Cell Therapy Product
Table 22. Nektar Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Nektar Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 24. Nektar Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 25. Nektar Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 26. Nektar Therapeutics Recent Developments
Table 27. Innate Pharma SA Corporation Information
Table 28. Innate Pharma SA Description and Business Overview
Table 29. Innate Pharma SA Natural Killer Cell Therapy Product
Table 30. Innate Pharma SA Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Innate Pharma SA Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 32. Innate Pharma SA Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 33. Innate Pharma SA Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 34. Innate Pharma SA Recent Developments
Table 35. Affimed Corporation Information
Table 36. Affimed Description and Business Overview
Table 37. Affimed Natural Killer Cell Therapy Product
Table 38. Affimed Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Affimed Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 40. Affimed Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 41. Affimed Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 42. Affimed Recent Developments
Table 43. Chipscreen Biosciences Corporation Information
Table 44. Chipscreen Biosciences Description and Business Overview
Table 45. Chipscreen Biosciences Natural Killer Cell Therapy Product
Table 46. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Chipscreen Biosciences Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 48. Chipscreen Biosciences Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 49. Chipscreen Biosciences Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 50. Chipscreen Biosciences Recent Developments
Table 51. Glycostem Therapeutics Corporation Information
Table 52. Glycostem Therapeutics Description and Business Overview
Table 53. Glycostem Therapeutics Natural Killer Cell Therapy Product
Table 54. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Glycostem Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 56. Glycostem Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 57. Glycostem Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 58. Glycostem Therapeutics Recent Developments
Table 59. Fate Therapeutics Corporation Information
Table 60. Fate Therapeutics Description and Business Overview
Table 61. Fate Therapeutics Natural Killer Cell Therapy Product
Table 62. Fate Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Fate Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 64. Fate Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 65. Fate Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 66. Fate Therapeutics Recent Developments
Table 67. Dragonfly Therapeutics Corporation Information
Table 68. Dragonfly Therapeutics Description and Business Overview
Table 69. Dragonfly Therapeutics Natural Killer Cell Therapy Product
Table 70. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Dragonfly Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 72. Dragonfly Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 73. Dragonfly Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 74. Dragonfly Therapeutics Recent Developments
Table 75. Kiadis Pharma Corporation Information
Table 76. Kiadis Pharma Description and Business Overview
Table 77. Kiadis Pharma Natural Killer Cell Therapy Product
Table 78. Kiadis Pharma Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Kiadis Pharma Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 80. Kiadis Pharma Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 81. Kiadis Pharma Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 82. Kiadis Pharma Recent Developments
Table 83. Nkarta Therapeutics Corporation Information
Table 84. Nkarta Therapeutics Description and Business Overview
Table 85. Nkarta Therapeutics Natural Killer Cell Therapy Product
Table 86. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Nkarta Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 88. Nkarta Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 89. Nkarta Therapeutics Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 90. Nkarta Therapeutics Recent Developments
Table 91. NantKwest Corporation Information
Table 92. NantKwest Description and Business Overview
Table 93. NantKwest Natural Killer Cell Therapy Product
Table 94. NantKwest Natural Killer Cell Therapy Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. NantKwest Revenue Proportion of Natural Killer Cell Therapy by Product in 2024
Table 96. NantKwest Revenue Proportion of Natural Killer Cell Therapy by Application in 2024
Table 97. NantKwest Revenue Proportion of Natural Killer Cell Therapy by Geographic Area in 2024
Table 98. NantKwest Recent Developments
Table 99. North America Natural Killer Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 100. North America Natural Killer Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 101. North America Natural Killer Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 102. North America Natural Killer Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 103. Asia-Pacific Natural Killer Cell Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 104. Asia-Pacific Natural Killer Cell Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 105. Asia-Pacific Natural Killer Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 106. Asia-Pacific Natural Killer Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 107. Europe Natural Killer Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 108. Europe Natural Killer Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 109. Europe Natural Killer Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 110. Europe Natural Killer Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 111. Latin America Natural Killer Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 112. Latin America Natural Killer Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 113. Latin America Natural Killer Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 114. Latin America Natural Killer Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 115. Middle East and Africa Natural Killer Cell Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 116. Middle East and Africa Natural Killer Cell Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 117. Middle East and Africa Natural Killer Cell Therapy Revenue by Type (2020-2025) & (US$ Million)
Table 118. Middle East and Africa Natural Killer Cell Therapy Revenue by Application (2020-2025) & (US$ Million)
Table 119. Natural Killer Cell Therapy Key Raw Materials, Industry Status and Trend
Table 120. Natural Killer Cell Therapy Key Raw Materials and Upstream Suppliers
Table 121. Natural Killer Cell Therapy Clients Status and Trend
Table 122. Natural Killer Cell Therapy Typical Clients
Table 123. Natural Killer Cell Therapy Distributors
Table 124. Natural Killer Cell Therapy Market Trends
Table 125. Natural Killer Cell Therapy Market Drivers
Table 126. Natural Killer Cell Therapy Market Challenges
Table 127. Natural Killer Cell Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Natural Killer Cell Therapy Product Picture
Figure 2. Global Natural Killer Cell Therapy Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Natural Killer Cell Therapy Revenue Market Share by Type in 2024 & 2031
Figure 4. NK Cell Therapies Product Picture
Figure 5. NK Cell Directed Antibodies Product Picture
Figure 6. Global Natural Killer Cell Therapy Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Natural Killer Cell Therapy Revenue Market Share by Application in 2024 & 2031
Figure 8. Cancer
Figure 9. Gastrointestinal Diseases
Figure 10. Others
Figure 11. Natural Killer Cell Therapy Report Years Considered
Figure 12. Global Natural Killer Cell Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Natural Killer Cell Therapy Market Size (2020-2031) & (US$ Million)
Figure 14. Global Natural Killer Cell Therapy Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Natural Killer Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 16. Global Natural Killer Cell Therapy Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Natural Killer Cell Therapy Revenue Market Share Forecast by Application (2020-2031)
Figure 18. NK Cell Therapies of Natural Killer Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 19. NK Cell Directed Antibodies of Natural Killer Cell Therapy Revenue Market Share by Application, 2024 VS 2031
Figure 20. Natural Killer Cell Therapy Revenue Share by Company (2024)
Figure 21. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. NK Cell Therapies Revenue Proportion by Company in 2024
Figure 23. NK Cell Directed Antibodies Revenue Proportion by Company in 2024
Figure 24. North America Natural Killer Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 25. North America Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 26. North America Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Natural Killer Cell Therapy Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 31. Europe Natural Killer Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Natural Killer Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 33. Europe Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 34. Europe Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Natural Killer Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Natural Killer Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Natural Killer Cell Therapy Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Application (2020-2025)
Figure 43. Natural Killer Cell Therapy Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Natural Killer Cell Therapy Raw Materials by Region in 2024
Figure 45. Natural Killer Cell Therapy Distribution Channels
Figure 46. Global Natural Killer Cell Therapy Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Natural Killer Cell Therapy Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
